Safe Selection of Genetically Manipulated Human Primary Keratinocytes with Very High Growth Potential Using CD24

    August 2007 in “ Molecular Therapy
    Valérie Bergoglio, Fernando Larcher, Odile Chevallier-Lagente, Alain Bernheim, Olivier Danos, Alain Sarasin, Marcela Del Río, Thierry Magnaldo
    Image
    Studysummary This study found that using ectopic expression of CD24 is a promising approach for selecting genetically modified human epidermal stem cells for safe cutaneous gene therapy in cancer-prone conditions.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results